None
Quote | Celgene Corporation Contingent Value Right (NASDAQ:CELGZ)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $0.469899 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 01/01/2020 10:40:42 am |
News | Celgene Corporation Contingent Value Right (NASDAQ:CELGZ)
Celgene Corporation (NASDAQ: CELG) announced today that following the completion of Celgene’s acquisition by Bristol-Myers Squibb Company (NYSE: BMY), Bristol-Myers Squibb and Celgene plan to transfer the listing of Celgene’s contingent value rights (NASDAQ: CELGZ) (“Celg...
With New Year's celebrations barely winding down, 2019 started with a bang with the announcement of the largest ever U.S. pharmaceutical deal. The news of Bristol-Myers Squibb ( BMY ) acquiring Celgene ( CELG ) immediately caused BMY stock to drop over 13% from $52.02 to $45.12 while Celgene s...
Message Board Posts | Celgene Corporation Contingent Value Right (NASDAQ:CELGZ)
Subject | By | Source | When |
---|---|---|---|
Will it bounce? | willlbone | investorshub | 09/26/2019 8:17:37 PM |
with 2.5% net sales cash payout in 2018 | celgz | investorshub | 02/01/2019 8:02:07 PM |
CELGZ buy 1.5266 | stocktrademan | investorshub | 08/24/2018 4:40:23 PM |
Eeek look like only 900 million this year. | 47cj2a | investorshub | 11/05/2015 11:23:46 PM |
Anyone still following this? Shouldn't Abraxane surpass | 47cj2a | investorshub | 09/28/2015 12:06:13 PM |
News, Short Squeeze, Breakout and More Instantly...
Celgene Corporation Contingent Value Right Company Name:
CELGZ Stock Symbol:
NASDAQ Market:
Celgene Corporation (NASDAQ: CELG) announced today that following the completion of Celgene’s acquisition by Bristol-Myers Squibb Company (NYSE: BMY), Bristol-Myers Squibb and Celgene plan to transfer the listing of Celgene’s contingent value rights (NASDAQ: CELGZ) (“Celg...